Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interferon-free therapy for hepatitis C: The hurdles amid a golden era.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver - 1 Sept 2015

Colombo Massimo

Abstract excerpt

The long awaited all-oral therapy for hepatitis C virus infection has officially been inaugurated by the registration of the hepatitis C nucleotide inhibitor sofosbuvir in a combination regimen with ribavirin. More recently, the oral array to treat hepatitis C has been enriched by the arrival of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 2-Naphthylamine
Share to Drug Therapy, Combination
Share to Liver Cirrhosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ribavirin

Share to Simeprevir

Share to Sofosbuvir

Share to Sulfonamides

Share to Uracil

Source

Identifiers

PMID: 25937625
DOI: 10.1016/j.dld.2015.04.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25937625-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interferon-free therapy for hepatitis C: The hurdles amid a golden era.PMID 25937625Read ↗

Hepatitis C drugs: the end of the pegylated interferon era and the emergence of all-oral interferon-free antiviral regimens: a concise review.Semantic proximity Read ↗

Interferon-free regimens: the near future, the likely and the not so likely.Semantic proximity Read ↗

Future perspectives: towards interferon-free regimens for HCV.Semantic proximity Read ↗

Ideal oral combinations to eradicate HCV: The role of ribavirin.Semantic proximity Read ↗

Optimal IFN-free therapy in treatment-naïve patients with HCV genotype 1 infection.Semantic proximity Read ↗

Interferon-free regimens for hepatitis C: combine and conquer.Semantic proximity Read ↗

Effectiveness of interferon-free therapy for the treatment of HCV-patients with compensated cirrhosis treated through the Irish early access program.Semantic proximity Read ↗

Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection.Semantic proximity Read ↗

Hepatitis C in 2011: A new standard of care and the race towards IFN-free therapy.Semantic proximity Read ↗

Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world setting.Semantic proximity Read ↗

Optimal interferon-free therapy in treatment-experienced chronic hepatitis C patients.Semantic proximity Read ↗

Concise review: Interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.